1. Home
  2. EFC vs PRCT Comparison

EFC vs PRCT Comparison

Compare EFC & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EFC

Ellington Financial Inc.

HOLD

Current Price

$11.75

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

HOLD

Current Price

$26.19

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFC
PRCT
Founded
2007
2009
Country
United States
United States
Employees
400
N/A
Industry
Real Estate
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EFC
PRCT
Price
$11.75
$26.19
Analyst Decision
Strong Buy
Buy
Analyst Count
5
11
Target Price
$14.55
$35.44
AVG Volume (30 Days)
1.6M
2.1M
Earning Date
01-01-0001
05-27-2026
Dividend Yield
13.01%
N/A
EPS Growth
N/A
1.71
EPS
N/A
N/A
Revenue
N/A
$308,054,000.00
Revenue This Year
N/A
$32.85
Revenue Next Year
$52.40
$24.66
P/E Ratio
$9.50
N/A
Revenue Growth
N/A
37.22
52 Week Low
$11.12
$19.35
52 Week High
$14.12
$64.89

Technical Indicators

Market Signals
Indicator
EFC
PRCT
Relative Strength Index (RSI) 30.06 47.20
Support Level $11.57 $19.35
Resistance Level $14.00 $29.24
Average True Range (ATR) 0.26 1.90
MACD 0.00 0.33
Stochastic Oscillator 17.50 63.47

Price Performance

Historical Comparison
EFC
PRCT

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: